$ZOM Increases Bought Deal Offering of Common Shares to $173.5 M

Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million.

today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 91,315,790 common shares of Zomedica, at a price to the public of $1.90 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 11, 2021, subject to satisfaction of customary closing conditions.

finance.yahoo.com/news/zomedica-corp-increases-previously-announced-040000607.html

biotechbiotechnologybiotechsbiotechstockbiotechstocksbiotehnologyChart PatternsFundamental AnalysisTrend Analysis

Also on:

Disclaimer